The specific features of pain syndrome in patients with hemophilia


Cite item

Abstract

Aim. To study the nature of pain in hemophilic arthropathy and its prevention ways used by patients with hemophilia. Subjects and methods. A prospective, multicenter, cross-sectional study was conducted to interview 136 patients with hemophilia A or B. The survey included 32 points, including questions about drug and nondrug pain treatment, as well as questionnaires to assess the severity of pain and its impact on daily life (Brief Pain Inventory) and those to identify a neuropathic pain component (PainDetect questionnaire). Results. 83 (75%) patients with hemophilia experienced acute pain associated with bleeding into the large joints; 44 (39%) patients had chronic pain that had lasted longer than six months; 33% assessed the moderate pain experienced in the past 24 hours as severe (more than 5-8 of the 10 scores). In addition to the above, only 32% of the respondents indicated that they had painless intervals within the last 24 hours. 75% of the hemophilia patients mentioned to have limited daily activities. 74% reported their partial or complete disability when pain occurred. 77% of the respondents pointed out that when having pain, they had experienced great difficulty walking. 55% of the hemophilia patients had sleep disorders because of pain. When acute pain occurred, only 91 (81%) respondents injected a factor VIII or IX preparation, 37% of the respondents used narcotic analgesics; 51% received different nonsteroidal anti-inflammatory drugs; 13% took paracetamol. Some patients indicated that they used alcohol and illegal narcotic drugs to relieve pain. Attention is drawn to the fact that the hemophilia patients very frequently took painkillers: 60% of the respondents used analgesics every month; of them 49% had them every week, 11% every day. Most patients (n=83 (74%)) stated that they treated pain (prescribed drugs) themselves; 49 (44%) patients held they were dissatisfied with their pain treatment. When the question as to how the analgesic you used could “remove’ pain was asked, only 12 (10%) patients answered that this could fully relieve the pain; 31 (26%) patients told that the pain was not reduced even by half. The study has shown that a neuropathic pain component is very common in hemophilia patients (31%). Conclusion. Pain in patients with hemophilia is a serious problem that negatively affects their quality of life, including their working capacity. The prevention and treatment of pain in hemophilia patients should involve the following: organization of educational activities and pain services; adequate treatment of acute pain; detection and prevention of a neuropathic pain component.

References

  1. Berntorp E, Shapiro AD. Modern haemophilia care. Lancet. 2011;379:1447-1456. doi: 10.1016/s0140-6736(11)61139-2
  2. Rodriguez-Merchan EC. Special features of total knee replacement in hemophilia. Expert Rev Hematol. 2013;6(6):637-641. doi: 10.1586/17474086.2013.856261
  3. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain(NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S140-151. doi: 10.1002/acr.20543
  4. Ван Роенн Дж.Х., Пэйс Дж.А., Преодер М.И. Диагностика и лечение боли. М.: БИНОМ; 2011.
  5. Badia X, Muriel C, Gracia A et al. Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain. Med Clin (Barc). 2003;110(1):51-59.
  6. Witkop M, Lambing A, Divine G et al. A national study of pain in the bleeding disorders community: a description of haemophilia pain. Haemophilia 2011;18(3):115-119. doi: 10.1111/j.1365-2516.2011.02709.x
  7. Grady JG. Broadening the view of acetaminophen hepatotoxicity. Hepatology. 2005;41:1151-1154. doi: 10.1002/hep.20988
  8. Шулутко Е.М., Левченко О.К., Городецкий В.М., Гемджян Э.Г., Коняшина Н.И., Кречетова А.В. Обезболивание больных гемофилией при ортопедических операциях. Терапевтический архив. 2014;86(5):56-61.
  9. Srivastava AK, Brewer EP, Mauser-Bunschoten et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):1-47. doi: 10.1111/j.1365-2516.2012.02909.x
  10. Rattray B, Nugent DJ, Young G. Rofecoxib as adjunctive therapy for haemophilicarthropathy. Haemophilia. 2005;11(3):140-144. doi: 10.1111/j.1365-2516.2005.01087.x
  11. Dirkmann D, Groeben H, Farhan H, Stahl DL, Eikermann M. Effects of parecoxib on analgesia benefit and blood loss following open prostatectomy: a multicentre randomized trial. BMCAnesthesiol. 2015;15:31. doi: 10.1186/s12871-015-0015-y
  12. Mathieson S, Maher CG, Terwee CB, Folly de Campos T, Lin CW. Neuropathic pain screening questionnaires have limited measurement properties. A systematic review. J Clin Epidemiol. 2015 Mar 13. doi: 10.1016/j.jclinepi.2015.03.010
  13. Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy:differential diagnosis and management. Am Fam Physician. 2010;81(7):887-891.

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies